Image 1
Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 0228-4241
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 0228-4241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
This text seems to be a graph description, showing the estimated proportion of patients with treatment failure on the y-axis and the number of days from randomization to treatment failure on the x-axis. The data seems to be related to a study involving Clonidine, and there are values of 60, 80, 100, 120, 140, 160, 180, and 200 along the x-axis.*
Image 5
Image 6
Clonidine hydrochloride is available in extended-release tablets. The tablets come in a container labelled NBCo28 4261:06 and contain 0.1mg of Clonidine hydrochloride, USP. The pharmacist should dispense the medication in a separate patient information leaflet to each patient and keep out of children's reach. The container has 60 tablets and is manufactured by Actvis Eleabeth Lic. Distributed by Actnis Prar, Purippam NJOTGSAUSA, the LOT/EXP is below.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
